title: Can hepatitis C virus infection and interferon-alpha undo the HLA-DRB1*0402/DQB1*0302 protection against rheumatoid arthritis?
authors.forename: L
authors.initials: L
authors.lastname: La Civita
authors.forename: P
authors.initials: P
authors.lastname: Fadda
authors.forename: C
authors.initials: C
authors.lastname: Gaudiano
authors.forename: C
authors.initials: C
authors.lastname: Bentivenga
authors.forename: I
authors.initials: I
authors.lastname: Olivieri
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000209:etiology*; D005260:Female; D020022:Genetic Predisposition to Disease; D006684:HLA-DR Antigens / Q000235:genetics*; D059811:HLA-DRB1 Chains; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D008875:Middle Aged
chemical_list: D000998:Antiviral Agents; D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; C553506:HLA-DRB1*04:02 antigen; D016898:Interferon-alpha